Billing and Coding: Allergy Testing - R1

This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (HI and Territories), and 01312 (NV).

Effective Date: October 01, 2020
Summary of Article Changes: Revisions are due to the annual ICD-10 Updates.
Addition of coding to Group 1/Group II/Group III/IV:
T40.415A: Adverse effect of fentanyl or fentanyl analogs, initial encounter
T40.415S: Adverse effect of fentanyl or fentanyl analogs, sequela
T40.425A: Adverse effect of tramadol, initial encounter
T40.425S: Adverse effect of tramadol, sequela
T40.495A: Adverse effect of other synthetic narcotics, initial encounter
T40.495S: Adverse effect of other synthetic narcotics, sequela
Deleted Code in Group I:
T40.4X5A: Adverse effect of other synthetic narcotics, initial encounter
T40.4X5S: Adverse effect of other synthetic narcotics, sequela
Deleted Code in Group II:
T40.4X5A: Adverse effect of other synthetic narcotics, initial encounter
T40.4X5S: Adverse effect of other synthetic narcotics, sequela
Deleted Code in Group IV:
T40.4X5A: Adverse effect of other synthetic narcotics, initial encounter
T40.4X5S: Adverse effect of other synthetic narcotics, sequela

Visit the Noridian Medicare Coverage Articles webpage to view the complete listing of locally hosted coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD.

 

            Last Updated Mon, 28 Sep 2020 13:26:37 +0000